Guest Editorial

Stopping NASH in its tracks: Lifestyle Intervention Key from Day 1

June 12, 2019
In this guest editorial, Joel E. Lavine, MD, PhD, chief of pediatric gastroenterology, hepatology, and nutrition at th e

Clinical decision tool helps predict Entyvio outcomes in ulcerative colitis

June 12, 2019
SAN DIEGO — A clinical decision tool could help predict treatment outcomes of patients with ulcerative colitis on Entyvio therapy and identify…

Colonic eosinophilia linked to depression

June 12, 2019
SAN DIEGO — Eosinophil counts in the colon are associated with current but not incident depression, according to study results presented at…

In the Journals

Sodium polystyrene sulfonate use tied to increased risk for adverse GI events

June 11, 2019
Sodium polystyrene sulfonate, a common treatment for hyperkalemia, was associated with an increased risk for serious adverse gastrointestinal events…

FDA News

Device to improve cleansing for colonoscopy receives FDA clearance

June 11, 2019
The FDA has given 510(k) clearance to the second generation of Motus GI’s Pure-Vu System, which helps provide adequate cleansing of a poorly…

Meeting News

‘Reassuring’ data on late Remicade discontinuation in pregnancy

June 11, 2019
SAN DIEGO — There appeared to be no difference in child outcomes whether a pregnant mother with inflammatory bowel disease discontinued…

Meeting NewsPerspective

Novel bile acid sequestrant relieves symptoms of GERD

June 10, 2019
SAN DIEGO — A novel bile acid sequestrant helped improve heartburn and regurgitation in patients with persistent GERD who continued receiving…

In the Journals

Parkinson’s disease rates lower in patients treated vs. untreated for HCV

June 10, 2019
Patients who received interferon-based antiviral therapy for chronic hepatitis C had a significantly lower incidence rate of Parkinson’s…

Meeting News

Patient-directed messaging improves colorectal cancer screening rates

June 10, 2019
SAN DIEGO — A messaging program tailored specifically for individual patients helped improve colorectal cancer screening rates compared with…

FDA News

FDA permits marketing of first IBS device for patients 11 to 18 years old

June 7, 2019
The FDA announced today that it permits marketing of the first medical device to help reduce functional abdominal pain for patients 11 to 18 years of…

In the Journals

‘Welcomed news’ of PPIs long-term safety reported

June 7, 2019
In a large, placebo-controlled trial, researchers found that Protonix was not linked with any adverse event — other than a possible association…

Top stories in gastroenterology: Legalized cannabis fails to increase hyperemesis syndrome rates, oral vancomycin assists with ulcerative colitis remission

June 7, 2019
All last week’s top stories in gastroenterology were from Healio’s live coverage of Digestive Disease Week, which recently wrapped up in…

Meeting News

Standardized ketogenic diet demonstrates ‘dramatic beneficial effects’ in patients with NASH

June 6, 2019
SAN DIEGO – A weight management program based on the ketogenic diet substantially improved metabolic parameters and markers of liver disease in…

Meeting NewsVideo

VIDEO: Stem cell therapy for IBD safe, effective but faces costly limitations

June 6, 2019
CLEVELAND — In this exclusive video from the Cleveland Clinic IBD Master Class, Amy Lightner, MD, associate professor of colorectal surgery at…

In the Journals

Constipation may need to be redefined to meet public perception

June 6, 2019
Many patients with constipation might not even recognize their condition, leaving researchers from King’s College London to call for new…

Meeting NewsPerspective

Mirikizumab effective in Crohn’s induction

June 5, 2019
SAN DIEGO — Patients with Crohn’s disease treated with mirikizumab for induction therapy experienced improvements to clinical and…

Meeting NewsPerspective

Thiopurines offer no clear benefit over Humira monotherapy in Crohn’s maintenance

June 5, 2019
SAN DIEGO — Patients with Crohn’s disease who continued thiopurines in addition to scheduled Humira maintenance therapy experienced no…

Meeting News

Velusetrag improves diabetic, idiopathic gastroparesis

June 4, 2019
SAN DIEGO — Velusetrag, an oral, highly selective 5-hydroxytryptamine receptor 4 agonist, effectively reduced symptoms and gastric emptying in…

Meeting NewsPerspective

Oral FMT with antibiotics does not improve symptoms of IBS-D

June 4, 2019
SAN DIEGO — Orally delivered fecal microbiota transplantation did not help reduce symptoms in patients with diarrhea-predominant irritable…

In the Journals

Phase 2 study shows promising results for C. difficile vaccine

June 3, 2019
An investigational vaccine for the prevention of Clostridioides difficile infection was safe, well-tolerated and immunogenic in healthy…